Difficulty: Medium
Average Score: 75%
Practice
Amoxicillin-clavulanate is the First-line treatment in vulvovaginal infections caused by
Correct answer
B
Rationale
In pediatric genitourinary disorders, amoxicillin-clavulanate is the first-line treatment for vulvovaginal infections caused by Staphylococcus aureus (option B). This combination antibiotic is effective against a broad spectrum of bacteria, including Staphylococcus aureus, which is a common pathogen in vulvovaginal infections. By combining amoxicillin with clavulanate, which inhibits beta-lactamase enzymes produced by some bacteria, the effectiveness of the treatment is enhanced.
Streptococcus pyogenes (option A) is more commonly associated with pharyngitis and skin infections rather than vulvovaginal infections. Haemophilus influenzae (option C) is not a common pathogen in vulvovaginal infections. Shigella (option D) typically causes gastrointestinal infections and is not a typical pathogen in vulvovaginal infections.
In an educational context, understanding the appropriate use of antibiotics in pediatric patients is crucial to provide effective treatment while minimizing the risk of antibiotic resistance. By knowing the correct pathogens associated with specific infections and the appropriate first-line treatments, healthcare providers can make informed decisions to promote positive patient outcomes and prevent the spread of resistant bacteria.
Streptococcus pyogenes (option A) is more commonly associated with pharyngitis and skin infections rather than vulvovaginal infections. Haemophilus influenzae (option C) is not a common pathogen in vulvovaginal infections. Shigella (option D) typically causes gastrointestinal infections and is not a typical pathogen in vulvovaginal infections.
In an educational context, understanding the appropriate use of antibiotics in pediatric patients is crucial to provide effective treatment while minimizing the risk of antibiotic resistance. By knowing the correct pathogens associated with specific infections and the appropriate first-line treatments, healthcare providers can make informed decisions to promote positive patient outcomes and prevent the spread of resistant bacteria.